September Regeneron News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for priority.

United statesUnited kingdomSouth africaSeptember regeneronGeorged yancopoulosTammy allenRegeneron velocimmuneVesna tosicHuman service office of theRegeneron velocimmune technologyTeva pharmaceutical industries ltdDepartment of healthEuropean unionPharmaceuticals incCenters for diseaseRegeneron pharmaceuticals inc